- GlobeNewswire•13 days ago
Osiris Announces Scientific Manuscript Comparing Impact of Preservation Methods on Tissue Integrity and Functionality is Available Electronically in Peer-Reviewed Journal
COLUMBIA, Md., April 13, 2017-- Osiris Therapeutics, Inc., a leading regenerative medicine company focused on developing and marketing products for wound care, orthopedics, and sports medicine, announced ...
- GlobeNewswire•22 days ago
Osiris Therapeutics to Present 29 Advanced Clinical and Scientific Abstracts, Including a Late-Breaking Abstract on its New Ambient Viable Tissue Preservation Technology
COLUMBIA, Md., April 04, 2017-- Osiris Therapeutics, Inc., a leading regenerative medicine company focused on developing and marketing products for wound care, orthopedics, and sports medicine, will present ...
- GlobeNewswire•26 days ago
COLUMBIA, Md., March 31, 2017-- Osiris Therapeutics, Inc., announced today the passing of one of its Board Members, Yves Huwyler.. "It deeply saddens me to announce the untimely loss of a dear friend ...
OSIR : Summary for OSIRIS THERAPE INC COM STK USD0 - Yahoo Finance
Osiris Therapeutics, Inc. (OSIR)
NasdaqGM - NasdaqGM Delayed Price. Currency in USD
Add to watchlist
|Day's Range||4.70 - 4.85|
|52 Week Range||2.67 - 7.39|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||115.48|
|Dividend & Yield||0.00 (0.00%)|
|1y Target Est||N/A|